With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Drs. Bakris, Agarwal, Calhoun, Sorrentino, and Toto present evidence-based data on critical cardiovascular, renal, and diabetes management issues to aid in developing appropriate strategies to control high blood pressure in the spectrum of patients with this disease.
Drs. Deepak Bhatt and Benjamin Scirica discuss current emerging trends for antiplatelet dosing, timing, and drug combinations in ACS patients as well as key differentiating features of investigational antiplatelet drugs.
A 48-year-old African American man has exertional palpitations and dyspnea, but without dyspnea or limitations at rest or with normal daily activities. Should early PAH be suspected in this patient?
Join Drs. Dorian, Camm, and Aliot as they discuss the latest management strategies in atrial fibrillation and Dr. Piccini as he reviews the latest from Cardiostim 2010.
With a greater understanding of the mechanisms of coagulation, anticoagulant therapy is moving toward targeted therapy with the promise of improved patient outcomes. But are we there yet? Dr Jeffrey Weitz presents a clinical update.
Current ACC/AHA guidelines emphasize the need for aggressive modification of risk factors and treatment with antiplatelet, antihypertensive, and lipid-lowering agents, and evidence suggests that many physicians fail to adhere to these guidelines. This educational initiative will engage physicians in a self-assessment activity developed specifically to address knowledge and competency in the management of patients with ACS.
Join Drs. Zipes and Sweeney for a discussion on the differences in effects of electrical therapy type for ventricular arrhythmias on mortality in ICD patients.
Dr. Hugh Calkins leads a panel of experts, Drs. Berger, Hocini, and Jalife, as they review the impact of AF and discuss the management strategies to avoid the consequences of AF or to restore normal function.
Drs. Storey, Kereiakes, and Montalescot discuss the use of point-of-care testing to assess antiplatelet responsiveness, including strategies for treating poor responders.
Read Dr. Kaszala's clinical update, "How Evolving Sensor Technology and Rate-Responsive Pacing Can Improve Clinical Outcomes in CI." Then join him and Dr. Ellenbogen as they present 3 case studies and further discuss this important topic.
Join Drs. Hacke and Diener as they give a neurologist's perspective on the potential impact of novel anticoagulants on the risk for stroke in patients with AF.
It is becoming clear that dual antiplatelet therapy may need frequent reevaluation and monitoring in patients following an acute coronary syndrome (ACS). Join Drs. Peter P. Toth and Christopher P. Cannon who will address a number of challenging decision points that can occur in the long-term management of these patients.
Data on almost 3000 transcatheter aortic-valve implantation patients were presented at EuroPCR 2010. Dr. Moat discusses the top-line findings with Drs. Eltchaninoff, Petronio, and Thomas. Then Dr. Manoharan gives the proctor's perspective.
Drs. Weber, Whelton, and Raij review the risks and benefits of current therapies for addressing arthritis pain and assess the potential utility of an emerging class of drug to address pain and maintain target blood pressure.